Media Assistance:
 Gila Reckess Senior Medical Sciences Writer reckessg@wustl.edu (314) 286-0109 |
Heart disease is the leading cause of death in America, and stroke is third. Combined they kill nearly a million men and women in the United States each year. Another 64 million Americans live with cardiovascular disease. Researchers and doctors working in the Washington University Cardiovascular Division explore all options available to them as they combat these diseases. They interact freely with expert faculty in many other departments to discover new and effective treatments for all types of cardiovascular disease. The WUSTL cardiovascular faculty includes more than 200 highly respected members, including experts in virtually every cardio-related field of study.
Browse the articles and experts below for more information regarding heart disease and stroke.
| Faculty Experts: |
|
Showing Heart / Stroke Experts 1 through 5 of 12. - Show More |
|
| James G. Miller Albert Gordon Hill Professor of Physics in Arts & Sciences (http://mednews.wustl.edu/sb/page/normal/758.html) Professor Miller's research focuses on the physics of anisotropic, inherently inhomogeneous media. These systematic studies of the anisotropic properties of the heart have led to fundamentally new insights. In 1998 the National Institutes of Health grant supporting this research was awarded MERIT status, ... Expertise: physics of anisotropic, inherently inhomogeneous media, anisotropic properties of the heart, diagnostic images of hearts, echocardiographic imagers Direct contact: (314) 935-6229 / james.g.miller@wustl.edu |
|||
| Brian Gage Associate professor of medicine (http://mednews.wustl.edu/sb/page/normal/716.html) Gage is an internist and health service researcher. He specializes in two related fields: antithrombotic therapy and stroke prevention. He has developed a formula that can help predict the risk of stroke in patients with atrial fibrillation. These patients have a fivefold increased risk of stroke. ... Expertise: antithrombotic therapy, stroke, atrial fibrillation Media assistance: (314) 286-0111 / williamsdia@wustl.edu |
|||
| Larry Taber Professor of Biomedical Engineering (http://mednews.wustl.edu/sb/page/normal/350.html) Taber has been probing the forces, stresses and deformations of the heart since the mid-1980s. A major focus of his work is to show that biomechanical forces may be as important as genetics in shaping the heart. Recently, Taber has developed a theory on tissue growth and morphogenesis--shape change--and ... Expertise: biomechanics of cardiovascular development, heart, embryo, blood vessels Direct contact: (314) 935-8544 / lat@biomed.wustl.edu |
|||
| Frank Yin Stephen and Camilla Brauer Professor of Biomedical Engineering (http://mednews.wustl.edu/sb/page/normal/349.html)
Frank C. P. Yin, M.D., Ph.D., the Stephen and Camilla Brauer Professor of Biomedical Engineering and chair of the biomedical engineering department, is a world-renowned biomedical engineer. Yin heads a dynamic, young department, not yet five years old and already ranked among the top 20 in the nation. ... Expertise: soft tissue mechanics, cell mechanics, hemodynamics Direct contact: (314) 935-6164 / yin@biomed.wustl.edu |
|||
| Ralph Damiano Jr. The John Shoenberg Professor of Surgery (http://mednews.wustl.edu/sb/page/normal/166.html)
The chief of cardiac surgery in the Division of Cariothoracic Surgery, Damiano is internationally recognized for his innovative research in surgical robotics and minimally invasive heart surgery. Expertise: surgical robotics, minimally invasive heart surgery, robotically assisted surgery, minimally invasive surgery, heart rhythm abnormalities Media assistance: (314) 286-0109 / reckessg@wustl.edu |
|
Showing Heart / Stroke Experts 1 through 5 of 12. - Show More |
|
| News Stories & Tip Sheets: |
|
Showing Heart / Stroke Stories 1 through 3 of 120. - Show More |
|
| New generation of heart disease treatment Gene directs stem cells to build the heart (http://mednews.wustl.edu/news/page/normal/11973.html) July 2, 2008 --
|
|||
| Anticancer, anti-heart Certain anticancer agents could be harmful to patients with heart disease (http://mednews.wustl.edu/news/page/normal/11940.html) June 20, 2008 -- A set of promising new anticancer agents could have unforeseen risks in individuals with heart disease, suggests research at the School of Medicine. The anticancer drugs — which go by the strange name of hedgehog antagonists — interfere with a biochemical process that promotes growth in some cancer cells. But the researchers showed that interfering with this biochemical process in mice with heart disease led to further deterioration of cardiac function and ultimately death. |
|||
| Beta blocking Many African-Americans have a gene that prolongs life after heart failure (http://mednews.wustl.edu/news/page/normal/11578.html) April 20, 2008 -- About 40 percent of African-Americans have a genetic variant that can protect them after heart failure and prolong their lives, according to research conducted at the School of Medicine and collaborating institutions. The genetic variant has an effect that resembles that of beta blockers, drugs widely prescribed for heart failure. The new study offers a reason why beta blockers don't appear to benefit some African-Americans. |
|
Showing Heart / Stroke Stories 1 through 3 of 120. - Show More |
|
| Related News Clips: |
|
Showing Heart / Stroke Clips 1 through 5 of 30. - Show More |
 Show More Heart / Stroke Clips |
|
| Eating Your Way to a Sturdy Heart
The New York Times May 13, 2008 -- Some of the best things you can do for your heart do not involve deprivation or medication. Simple and even pleasurable changes in the foods you eat can rival medication in terms of the benefit to your heart. WUSTL epidemiology professor Graham Colditz comments on why many people are not getting the message. |
| Genes Explain Race Disparity in Response to a Heart Drug
The New York Times and 5 others April 29, 2008 -- Doctors who treat patients with heart failure have long been puzzled that many black patients seem to not respond to a class of drugs called beta blockers. Now researchers at WUSTL and U. Maryland have found that these nonresponsive patients have a slightly altered version of a gene that muscles use to control responses to nerve signals. The discovery raises questions about whom to treat with beta blockers and how to decide, researchers say. But, they add, its implications go beyond heart failure. WUSTL cardiologist and principal investigator Gerald Dorn comments. |
| Cutting Phosphate May Protect Kidney Patients From Heart Trouble
The Washington Post and 11 others April 24, 2008 -- Readily available phosphate-binding drugs could help prevent heart disease in people with chronic kidney disease, a new study in the the Journal of the American Society of Nephrology finds. WUSTL researchers led by pediatric nephrology specialist Keith Hruska and pediatrics instructor Suresh Mathew comment. |
| Reverse Your Risk
Good Housekeeping April 1, 2008 -- WUSTL researcher Kathryn Diemer, clinical director of WUSTL's Bone Health Program, talks about bone-mineral density and other fracture risks in aging women. |
| Angioplasty's golden era may be fading
USA Today and 1 others March 27, 2008 -- Three major studies published in the past two years indicate that using the angioplasty to open blocked arteries to treat chest pain, or angina, may be riskier and no more beneficial than medication. WUSTL cardiologist Michael Rich comments on the study. |
|
Related Information Related Links:
Related Groups:
|
Download
